{"nctId":"NCT01483118","briefTitle":"Cinnamon Extract on Menstrual Cycles in PolyCystic Ovary Syndrome (PCOS)","startDateStruct":{"date":"2011-03"},"conditions":["Polycystic Ovary Syndrome"],"count":45,"armGroups":[{"label":"Cinnamon Extract Arm","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Cinnamon Extract"]},{"label":"Placebo Arm","type":"PLACEBO_COMPARATOR","interventionNames":["Dietary Supplement: Placebo"]}],"interventions":[{"name":"Cinnamon Extract","otherNames":["Cinnulin PF"]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients aged greater than 18 years of age\n* Ability to understand and willingness to comply with the study protocol\n* Written informed consent\n* Patients meeting the Rotterdam PCOS workshop criteria for polycystic ovary syndrome, defined by oligomenorrhea or amenorrhea and at least one of the following two signs: clinical or biochemical evidence of hyperandrogenism or ultrasound finding of polycystic appearing ovaries.\n\nExclusion Criteria:\n\n* Current pregnancy or lactation\n* Liver disease or elevated liver enzymes\n* Established diagnosis of diabetes mellitus\n* Abnormal serum glucose levels either at fasting or after the 2-hr oral glucose tolerance test meeting criteria for the diagnosis of diabetes mellitus according to the American Diabetes Association.\n* Insulin sensitizing treatment within 3 months prior to or during the eight week study period.\n* Hormonal treatment involving estrogen or progesterone 3 months prior to or during the study period, with the exception of medroxyprogesterone acetate for withdrawal bleeding.\n* Systemic or inhaled corticosteroids.\n* Known hypersensitive reaction to cinnamon.\n* Patients with seizure disorders, known cardiovascular disease, or cerebrovascular disease.\n* Body mass index (BMI)range 20-50 (excluding all women with BMI under 20 or over 50).","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","maximumAge":"38 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Menses During the Six Month Study Period.","description":"Ovulatory cycles will be confirmed by serum progesterone levels.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".42","spread":null},{"groupId":"OG001","value":".42","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":".75","spread":null},{"groupId":"OG001","value":".25","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Insulin Resistance","description":"The changes in insulin resistance parameters in overweight patients with PCOS between baseline and after 6 months of daily cinnamon compared to the corresponding change in patients receiving 6 months of placebo. Higher values of insulin resistance represent a worse outcome. A higher value Homeostasis Model of Insulin Resistance indicates more insulin resistance so higher values are worse outcomes (a score of \\>2 is considered healthy for adults with scores \\>5 being considered severe insulin resistance). For the Quant. Insulin Sensitivity Check Index, a lower value indicates more insulin resistance so lower values are worse outcomes (values can range from .45, which is considered normal in health individuals and .30, which is characteristic of diabetes).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":null},{"groupId":"OG001","value":"1.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":null},{"groupId":"OG001","value":"1.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":".34","spread":null},{"groupId":"OG001","value":".35","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":".33","spread":null},{"groupId":"OG001","value":".37","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Glucose Response","description":"Change in Glucose Response - area under the curve (AUC), trapezoidal method - in overweight patients with PCOS between baseline and after 6 months of daily cinnamon compared to the corresponding change in patient receiving 6 months of placebo. Fasting blood samples were drawn followed by a 2 hour glucose tolerance test with blood draws at 30, 60, and 120min post glucose ingestion.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16,485","spread":null},{"groupId":"OG001","value":"13,298","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16,515","spread":null},{"groupId":"OG001","value":"15,420","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":23},"commonTop":["Headache","Menstrual cramps","Back pain","Cold","Nausea"]}}}